Skip to content

Comparison of safety and effectiveness of continuous and cycled blue light therapy of newborns with jaundice

Comparison of safety profile and effectiveness of Intermittent vs Conventional Phototherapy in Moderately Hyperbilirubinemic Newborns (more than 35 weeks Gestational Age)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/01/011072
Enrollment
150
Registered
2018-01-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Neonatal Jaundice

Interventions

Intervention1: Intermittent phototherapy: Intermittent phototherapy with 1 hour on and 2 hours off phototherapy with either LED or CFL light with matched flux recording. Duration will be till babies b

Sponsors

Sasi Bhushan Gottimukkala
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Intermittent vs Continuous Phototherapy

Exclusion criteria

Exclusion criteria: Neonates with bilirubin in the exchange transfusion range, as per AAP charts Significant haemolytic jaundice (One or more of the following Low haemoglobin for gestational age Direct antibody test positive Rh incompatilibility setting with antenatal investigations showing evidence of isoimmunisation like Indirect antibody test positive, elevated middle cerebral peak systolic velocity in fetal Doppler USG, presence of hepatosplenomegaly and hydrops in foetal ultrasound) Already received > 5 hours of phototherapy Neonates with major congenital anomalies Neonates with birth asphyxia Significant hemodynamic instability Neonates with significant conjugated hyperbilirubinemia

Design outcomes

Primary

MeasureTime frame
Effectiveness of Phototherapy -Rate of fall of Bilirubin -Duration of PhototherapyTimepoint: At baseline, then after every 12 hours till babies bilirubin values come down 2 mg/dl below the cutoff according to AAP chart for phototherapy.

Secondary

MeasureTime frame
Parental Satisfaction Serum NO levels Serum calcium Vitamin D levels Temperature Skin rashes DNA breakage analysisTimepoint: At Baseline and at discharge i.e. when babies bilirubin values come down 2 mg/dl below the cutoff according to AAP chart for phototherapy.

Countries

India

Contacts

Public ContactDr Giridhar Sethuraman

Chettinad Hospital and Research Institute

sasigottimukkala@gmail.com9989399788

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 15, 2026